This week in Other Barks & Bites: the U.S. Court of Appeals for the Federal Circuit issued several precedential decisions this week, correcting the U.S. International Trade Commission’s economic prong analysis for the domestic industry requirement of Section 337, finding that petitioners at the Patent Trial and Appeal Board have no self-executing discovery obligations to present evidence from parallel ITC proceedings, and more; strong global demand for AI chips buoys Broadcom’s first quarter results; a new IFI CLAIMS patent report shows Novo Nordisk leading pharmaceutical firms worldwide in anti-obesity drug patent filings; and more.

Full Article Available Here